Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds

Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds

Ebola virus (EBOV) is one of the most lethal pathogens that can infect humans. The Ebola viral protein VP35 (EBOV VP35) inhibits host IFN-α/β production by interfering with host immune responses to viral invasion and is thus considered as a plausible drug target. The aim of this study was to identif...

Full description

Bibliographic Details
Main Authors:	Louis K. S. Darko, Emmanuel Broni, Dominic S. Y. Amuzu, Michael D. Wilson, Christian S. Parry, Samuel K. Kwofie
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Biomedicines
Subjects:	Ebola virus molecular docking molecular dynamics simulations Ebola virus protein VP35 Ebola virus inhibitors
Online Access:	https://www.mdpi.com/2227-9059/9/12/1796

Similar Items

Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors
by: Emmanuel Broni, et al.
Published: (2023-03-01)

Structural and Functional Aspects of Ebola Virus Proteins
by: Sahil Jain, et al.
Published: (2021-10-01)

Ebola Virus Disease
by: Necla TÜLEK, et al.
Published: (2015-06-01)

Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity
by: Lin Zhu, et al.
Published: (2024-01-01)

Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola
by: Jennifer K. Legardy-Williams, et al.
Published: (2020-03-01)

Novel Antiviral Molecules against Ebola Virus Infection
by: Mila Collados Rodríguez, et al.
Published: (2023-09-01)

Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions
by: Linda Bus-Jacobs, et al.
Published: (2024-04-01)

Corrigendum: Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
by: Michelle L. Pleet, et al.
Published: (2018-04-01)

Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain
by: Nodoka Kasajima, et al.
Published: (2021-11-01)

Regional Spread of Ebola Virus, West Africa, 2014
by: Gabriel Rainisch, et al.
Published: (2015-03-01)

Ebola Virus Disease Vaccines: Development, Current Perspectives & Challenges
by: Sumira Malik, et al.
Published: (2023-01-01)

Measles Cases during Ebola Outbreak, West Africa, 2013–2106
by: Francesca Colavita, et al.
Published: (2017-06-01)

The Politics of Fear: Médecins Sans Frontières and the West African Ebola Epidemic
by: Keith Hamilton
Published: (2017-11-01)

Cluster of Ebola Virus Disease, Bong and Montserrado Counties, Liberia
by: Tolbert G. Nyenswah, et al.
Published: (2015-07-01)

Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies
by: Supriya Ravichandran, et al.
Published: (2022-08-01)

Evaluation of fendiline treatment in VP40 system with nucleation-elongation process: a computational model of Ebola virus matrix protein assembly
by: Xiao Liu, et al.
Published: (2024-04-01)

Therapeutic Strategies against Ebola Virus Infection
by: Ching-Hsuan Liu, et al.
Published: (2022-03-01)

Deterministic model for West African Ebola epidemic growth dynamics /
by: Philemon Manliura Datilo, 1969-, author 639231, et al.
Published: (2020)

Deterministic model for West African Ebola epidemic growth dynamics /
by: Philemon Manliura Datilo, 1969-, author 639231
Published: (2020)

Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
by: Kuldeep Dhama, et al.
Published: (2018-08-01)

The Minor Matrix Protein VP24 from Ebola Virus Lacks Direct Lipid-Binding Properties
by: Yuan Su, et al.
Published: (2020-08-01)

Mapping the global research output on Ebola vaccine from research indexed in web of science and scopus: a comprehensive bibliometric analysis
by: Tosin Yinka Akintunde, et al.
Published: (2021-11-01)

Anticipated Negative Responses by Students to Possible Ebola Virus Outbreak, Guangzhou, China
by: Joseph T.F. Lau, et al.
Published: (2016-01-01)

Warning: Ebola arrived in Columbus land
by: Felipe Coiffman
Published: (2016-07-01)

Epidemiological dynamics of Ebola outbreaks
by: Thomas House
Published: (2014-09-01)

The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking
by: Angela R. Harrison, et al.
Published: (2021-08-01)

Continental concerted efforts to control the seventh outbreak of Ebola Virus Disease in Uganda: the first 90 days of the response
by: Jane Ruth Aceng, et al.
Published: (2023-09-01)

Extracellular vesicle storm during the course of Ebola virus infection in primates
by: Andrea Vucetic, et al.
Published: (2023-11-01)

Ebola virus (<i>Filoviridae: Ebolavirus: Zaire ebolavirus</i>): fatal adaptation mutations
by: I. V. Dolzhikova, et al.
Published: (2021-03-01)

Magnetic Resonance Imaging for Monitoring of Hepatic Disease Induced by Ebola Virus: a Nonhuman Primate Proof-of-Concept Study
by: Ji Hyun Lee, et al.
Published: (2023-06-01)

<i>Bacillus paranthracis</i> Isolate from Blood of Fatal Ebola Virus Disease Case
by: M. Jeremiah Matson, et al.
Published: (2020-06-01)

Ebola Virus Infection
by: İlkay BOZKURT, et al.
Published: (2014-12-01)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
by: Emmie de Wit, et al.
Published: (2015-04-01)

Lessons from Pasteur may help prevent the deadly relapse of Ebola in patients: Using contingency vaccination to avoid Ebola relapse in immune-privileged organs
by: Wei Ye, et al.
Published: (2023-03-01)

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates
by: John J. Suschak, et al.
Published: (2019-10-01)

Ebola virus disease: Recent advances in diagnostics and therapeutics
by: Supriya Jagga, et al.
Published: (2019-01-01)

Ebola drug trial: a ray of hope
by: Shobanbabu Varthya, et al.
Published: (2019-12-01)

Evaluation of the Benefits and Risks of Introducing Ebola Community Care Centers, Sierra Leone
by: Adam J. Kucharski, et al.
Published: (2015-03-01)

Mucosal Challenge Ferret Models of Ebola Virus Disease
by: Trevor Brasel, et al.
Published: (2021-03-01)

Long-Term Decrease in Intraocular Pressure in Survivors of Ebola Virus Disease in the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Study
by: Shwetha Mudalegundi, BS, BSPH, et al.
Published: (2023-06-01)